CEL-SCI and Bellicum Pharmaceuticals among healthcare gainers; INSYS Therapeutics leads the losers

|About: Provention Bio, Inc. (PRVB)|By:, SA News Editor

Gainers: Provention Bio (NASDAQ:PRVB) +306%. CEL-SCI (NYSEMKT:CVM) +22%. Xynomic Pharmaceuticals Holdings (NASDAQ:XYN) +19%. Bellicum Pharmaceuticals (NASDAQ:BLCM) +14%. Tyme Technologies (NASDAQ:TYME) +14%.

Losers: INSYS Therapeutics (NASDAQ:INSY) -56%. ReWalk Robotics (NASDAQ:RWLK) -19%. ContraVir Pharmaceuticals (NASDAQ:CTRV) -14%. Novavax (NASDAQ:NVAX) -12%. Sienna Biopharmaceuticals (NASDAQ:SNNA) -12%.

Subscribe for full text news in your inbox